Journal of Cardiac Failure
Volume 14, Issue 1 , Pages 27-34 , February 2008

The Relationship Between Anemia, Change in Hematocrit Over Time and Change in Health Status in Patients With Heart Failure After Myocardial Infarction

  • Mikhail Kosiborod, MD

      Affiliations

    • Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, Missouri
    • ,
  • Harlan M. Krumholz, MD, SM

      Affiliations

    • Yale University, New Haven, Connecticut
    • ,
  • Philip G. Jones, MS

      Affiliations

    • Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, Missouri
    • ,
  • Bertram Pitt, MD

      Affiliations

    • University of Michigan, Ann Arbor, Michigan
    • ,
  • John A. Spertus, MD, MPH

      Affiliations

    • Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, Missouri
    • Corresponding Author InformationReprint requests: John A. Spertus, MD, MPH, Mid America Heart Institute, 4401 Wornall Road, Kansas City, MO 64111.

Received 22 May 2007 ,Revised 23 September 2007 ,Accepted 27 September 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funding Source: Funding for this study was provided by Pfizer, Inc., New York, NY.

 Conflict of Interest Disclosures: Dr. Spertus discloses that he developed and owns the copyright to the Kansas City Cardiomyopathy Questionnaire; is a consultant for Amgen, United Healthcare, and Otsuka; and receives research grant support from the National Institutes of Health, Amgen, Lilly, Roche Diagnostics, Atherotech, and the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). Dr. Krumholz discloses that he has research contracts with the Colorado Foundation for Medical Care and the American College of Cardiology, serves on the advisory boards for Amgen, Alere and United Healthcare, is a subject matter expert for VHA, Inc., and is Editor-in-Chief of Journal Watch Cardiology of the Massachusetts Medical Society. Dr. Pitt discloses that he is a consultant for Pfizer and Novartis.

PII: S1071-9164(07)01084-6

doi: 10.1016/j.cardfail.2007.09.009

Journal of Cardiac Failure
Volume 14, Issue 1 , Pages 27-34 , February 2008

Article Tools

* Image Usage & Resolution